Two Separate Cuts. One Pattern.

The Trump administration has made two distinct moves in the drug policy space — and mainstream media is treating them as unrelated. They aren't.

First: federal efforts to study how many Americans are driving impaired on drugs have stalled, according to reporting by the Washington Post. Second: the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a letter in April ordering grantees to stop using federal funds to purchase or distribute fentanyl test strips and other drug-testing kits.

Taken together, the administration is cutting both the tools that measure the drug crisis and the tools that help people survive it.

The Drugged-Driving Research Problem

The federal government cannot say with precision how many fatal crashes involve drug-impaired drivers. The data collection systems that would provide this answer have been underfunded and inconsistent for years — and efforts to fix them have now stalled under the current administration, according to the Washington Post.

This isn't a new problem. A 2011 white paper commissioned by the National Institute on Drug Abuse and authored by researchers including Dr. Robert L. DuPont and Dr. Barry K. Logan — published through the Office of Justice Programs — identified the exact same gap over a decade ago. The paper called for standardized drugged-driver testing, better data collection, and consistent impairment research. That was 2011.

We've had 14 years of knowing this data gap exists. It's still not fixed. And now the funding to fix it has dried up further.

The Fentanyl Test Strip Ban

SAMHSA's April letter marked a shift in policy.

The agency told grant recipients that its funding cannot be used to purchase or distribute fentanyl test strips, xylazine strips, or strips testing for medetomidine — a novel tranquilizer increasingly showing up in the street drug supply.

The stated reason: test strips "facilitate illicit drug use" and are "incompatible with federal laws."

The Biden administration had permitted SAMHSA funding for these strips starting in 2021, specifically to reduce deaths from fentanyl contamination in other drugs. Dealers mix fentanyl into heroin, cocaine, and counterfeit pills because it's cheap and potent. Users often don't know it's there. Test strips let people check before they use.

Daniel Fishbein, policy manager of federal affairs for the Drug Policy Alliance, told The Guardian: "What we keep hearing from the administration is that they believe that fentanyl test strips promote drug use. Based on the research that I've reviewed, that's simply not the case."

Maia Szalavitz, a New York Times columnist and author of Undoing Drugs: The Untold Story of Harm Reduction and the Future of Addiction, said: "It's going to kill people."

The Internal Contradiction

The same week SAMHSA issued that letter banning test strip funding, the White House published its National Drug Control Strategy — which praised rapid test strips as useful tools for detecting fentanyl, according to The Guardian.

The White House drug strategy document supports test strips. SAMHSA's letter bans funding for them. Same administration. Same week. This is not a coherent policy — different factions inside one administration are pulling in opposite directions while people die in the gap between them.

HHS, which oversees SAMHSA, has been led by RFK Jr., whose ideological bent is firmly anti-harm-reduction and pro-abstinence. The drug czar's office apparently didn't get the memo — or didn't care enough to coordinate.

This internal contradiction has received minimal scrutiny.

What the Left Gets Wrong

The Washington Post and The Guardian frame this primarily as a Trump problem. And the specific cuts happened under Trump — that's fair.

But the drugged-driving research gap has existed for decades across multiple administrations — Republican and Democrat alike. The 2011 federal white paper cited above proves this was a known, unfixed problem under Obama. The Biden administration permitted test strip funding in 2021 but did NOT solve the underlying research infrastructure failures in four years.

Blaming only Trump while ignoring 14 years of bipartisan inaction on drugged-driving data misses the fuller picture. The problem is real, and it predates the current administration.

What the Right Isn't Saying Either

Conservative media has been largely silent on both stories. That silence is telling.

If a Biden-era agency cut road safety research funding, Fox News would run it for a week. Federal bureaucrats stalling data collection that could save lives on American highways is a legitimate government accountability story. It doesn't become less legitimate because it happened under a Republican administration.

And the fentanyl test strip ban — whatever your view on harm reduction philosophy — is a policy with a body count attached to it. That deserves honest reporting, not ideological protection.

The Facts

American roads are more dangerous when we don't know how many drugged drivers are on them. American drug users are more likely to die accidentally when they can't test what's in their supply.

Both of those statements are true regardless of your politics.

The Trump administration just made both problems worse — while its own documents contradict its own agencies. Meanwhile, mainstream left media blames Trump exclusively, conservative media ignores the story, and nobody is asking why 14 years of known research failures never got fixed by anyone.

Regular people drive those roads. Regular families lose people to accidental overdoses. They deserve straight answers — not a policy debate that changes based on who's in power.